An Engineered Specificity of Anti-Neoplastic Agent Loaded Magnetic Nanoparticles for the Treatment of Breast Cancer
Open Access
Abstract
Nanoparticles have gained increased attention due to the prospection of drug delivery at target sites, thus limiting the systemic effects of the drugs. Their efficiency was further improved by adding special carriers such as magnetite (Fe3O4). It is one of the extensively used oxides of iron for both pharmaceutical and biomedical applications owing to its ease of preparation and biocompatibility. In this work, Gemcitabine magnetic nanoparticles were prepared using Fe3O4 and chitosan as the primary ingredients. Optimization was accomplished by Box–Behnken Design and factor interactions were evaluated. The desirability function approach was made to enhance the formulation concerning particle size, polydispersity index, and zeta potential. Based on this, optimized magnetic nanoparticles (O-MNP) were formulated with 300 mg of Fe3O4, 297.7 mg of chitosan, and a sonication time of 2.4 h, which can achieve the prerequisites of the target formulation. All other in vitro parameters were found to be following the requirement. In vitro cytotoxic studies for O-MNP were performed using cell cultures of breast cancer (MCF-7), leukemia (THP-1), prostate cancer (PC-3), and lung cancer (A549). O-MNP showed maximum inhibition growth with MCF-7 cell lines rather than other cell lines. The data observed here demonstrates the potential of magnetic nanoparticles of gemcitabine in treating breast cancers.Keywords
Funding Information
- Deanship of Scientific Research, King Faisal University (206113)
This publication has 60 references indexed in Scilit:
- Biocompatibility of Chitosan Carriers with Application in Drug DeliveryJournal of Functional Biomaterials, 2012
- Magnetic nanovectors for drug deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Recent advances in novel targeted therapies for HER2-positive breast cancerAnti-Cancer Drugs, 2012
- Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro studyInternational Journal of Nanomedicine, 2012
- Superior Preclinical Efficacy of Gemcitabine Developed As Chitosan Nanoparticulate SystemBiomacromolecules, 2010
- Synthesis and Characterization of Multifunctional Chitosan- MnFe2O4 Nanoparticles for Magnetic Hyperthermia and Drug DeliveryMaterials, 2010
- Functionalisation of nanoparticles for biomedical applicationsNano Today, 2010
- Gemcitabine: vascular toxicity and prothrombotic potentialExpert Opinion on Drug Safety, 2008
- In Vitro Controlled Release of Alfuzosin Hydrochloride Using HPMC-Based Matrix Tablets and Its Comparison with Marketed ProductPharmaceutical Development and Technology, 2007
- Genotyping and drug response: Use of single nucleotide polymorphisms (SNPs) versus haplotypes to predict albuterol efficacyAAPS PharmSci, 2001